For severe chronic rhinosinusitis with nasal polyps, novel stapokibart reduced symptoms and polyp size atop treatment with a daily intranasal corticosteroid, the randomized CROWNS-2 trial showed. When ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results